氯己定与莫匹罗星清除出院后耐甲氧西林金黄色葡萄球菌定植:消除抗生素耐药改变生活试验的二次分析
CLEAR试验的二次分析纳入2121例出院后耐甲氧西林金黄色葡萄球菌(MRSA)感染或定植成人,1:1随机接受预防教育或教育联合氯己定与莫匹罗星去定植。1个月时去定植组MRSA定植低于仅教育组(OR=0.44;95%CI,0.36-0.54;P≤0.001),鼻、咽、腋窝/腹股沟部位定植均降低,差异持续至9个月(伤口部位因样本量小除外)。依从性越高,MRSA定植越低(P≤0.01)。
要点
- 出院后重复去定植方案降低MRSA定植(OR=0.44;95%CI,0.36-0.54;P≤0.001)。
- 鼻(OR=0.34)、咽(OR=0.55)、腋窝/腹股沟(OR=0.57)定植均降低。
- 差异持续至9个月,伤口部位因样本量较小除外。
核心结论
- 在随机临床试验中,对MRSA携带者出院后重复去定植方案降低了MRSA总体及多个身体部位的定植。
- 较高的治疗依从性与MRSA定植更大幅度降低相关。
研究设计与样本
- 大型、多中心、随机临床试验的二次分析,纳入出院后MRSA感染或定植的成人患者。
- 参与者1:1随机接受MRSA预防教育或教育联合局部氯己定、口服氯己定及鼻用莫匹罗星去定植。
- 在基线及随机后1、3、6、9个月对鼻、咽、腋窝/腹股沟及伤口(如适用)进行拭子采样。
主要发现
- 2121例参与者中,1058例随机分配至去定植组。
- 1个月时,去定植组MRSA定植低于仅教育组(OR=0.44;95%CI,0.36-0.54;P≤0.001)。
- 鼻部定植降低(OR=0.34;95%CI,0.27-0.42;P<0.001),咽部定植降低(OR=0.55;95%CI,0.42-0.73;P<0.001),腋窝/腹股沟定植降低(OR=0.57;95%CI,0.43-0.75;P<0.001)。
- 这些差异持续至第9个月,但伤口部位除外,该部位样本量相对较小。
- 较高的方案依从性与较低的MRSA定植相关(P≤0.01)。
局限性
- 伤口部位样本量相对较小。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The CLEAR Trial demonstrated that a multisite body decolonization regimen reduced post-discharge infection and hospitalization in methicillin-resistant Staphylococcus aureus (MRSA) carriers. Here, we describe decolonization efficacy. METHODS: We performed a large, multicenter, randomized clinical trial of MRSA decolonization among adult patients after hospital discharge with MRSA infection or colonization. Participants were randomized 1:1 to either MRSA prevention education or education plus decolonization with topical chlorhexidine, oral chlorhexidine, and nasal mupirocin. Participants were swabbed in the nares, throat, axilla/groin, and wound (if applicable) at baseline and 1, 3, 6, and 9 months after randomization. The primary outcomes of this study are follow-up colonization differences between groups. RESULTS: Among 2121 participants, 1058 were randomized to decolonization. By 1 month, MRSA colonization was lower in the decolonization group compared with the education-only group (odds ration [OR] = 0.44; 95% confidence interval [CI], .36-.54; P ≤ .001). A similar magnitude of reduction was seen in the nares (OR = 0.34; 95% CI, .27-.42; P < .001), throat (OR = 0.55; 95% CI, .42-.73; P < .001), and axilla/groin (OR = 0.57; 95% CI, .43-.75; P < .001). These differences persisted through month 9 except at the wound site, which had a relatively small sample size. Higher regimen adherence was associated with lower MRSA colonization (P ≤ .01). CONCLUSIONS: In a randomized, clinical trial, a repeated post-discharge decolonization regimen for MRSA carriers reduced MRSA colonization overall and at multiple body sites. Higher treatment adherence was associated with greater reductions in MRSA colonization.
引用
- Miller LG, Singh R, Eells SJ, et al. Chlorhexidine and Mupirocin for Clearance of Methicillin-Resistant Staphylococcus aureus Colonization After Hospital Discharge: A Secondary Analysis of the Changing Lives by Eradicating Antibiotic Resistance Trial. Clin Infect Dis. 2023. PMID: 35640877. doi:10.1093/cid/ciac402
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。